BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
7/28/21 Bristol Myers Squibb (BMY) Opdivo for Esophageal Cancer Subscribers Only Subscribers Only Subscribers Only
7/28/21 NewAmsterdam Obicetrapib for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only Subscribers Only
7/21/21 Aprea (APRE) Eprenetapopt for Myelodysplastic Syndrome (MDS) Subscribers Only Subscribers Only Subscribers Only
7/21/21 Aprea (APRE) Eprenetapopt for Acute Myelogenous Leukemia (AML) Subscribers Only Subscribers Only Subscribers Only
7/20/21 Vericel Corporation (VCEL) NexoBrid for Burn Injury Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/16/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
06/30/21 Subscribers Only Subscribers Only Partnership - Acquisition Completion
07/28/21 Subscribers Only Subscribers Only Company - Analyst/R&D Update
07/29/21 Subscribers Only Subscribers Only Trial Data - Top-Line Results
07/29/21 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Back to the top Back to the top